| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 41.96B | 49.96B | 47.65B | 41.92B | 46.27B |
| Gross Profit | 32.45B | 39.11B | 33.99B | 30.81B | 35.28B |
| EBITDA | 19.75B | 16.99B | 15.91B | 13.65B | 17.62B |
| Net Income | 16.38B | 15.35B | 12.75B | 11.05B | 13.35B |
Balance Sheet | |||||
| Total Assets | 1.08T | 814.27B | 905.51B | 846.57B | 806.65B |
| Cash, Cash Equivalents and Short-Term Investments | 892.42B | 387.54B | 345.52B | 337.71B | 334.03B |
| Total Debt | 303.39B | 178.80B | 238.42B | 201.39B | 211.40B |
| Total Liabilities | 870.35B | 622.38B | 723.29B | 678.71B | 654.62B |
| Stockholders Equity | 206.94B | 191.67B | 179.11B | 165.10B | 148.42B |
Cash Flow | |||||
| Free Cash Flow | -13.82B | 66.36B | -33.13B | 65.73B | -47.60B |
| Operating Cash Flow | -12.60B | 68.17B | -31.46B | 67.16B | -44.64B |
| Investing Cash Flow | -42.10B | 20.50B | -6.26B | -16.71B | -262.04M |
| Financing Cash Flow | 110.79B | -59.67B | 17.96B | -26.70B | 44.21B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$153.21B | 5.14 | 9.03% | 0.97% | 8.40% | 78.28% | |
69 Neutral | HK$306.54B | 8.17 | 6.85% | 2.75% | 91.20% | 30.16% | |
68 Neutral | HK$185.92B | 4.86 | 10.70% | 2.80% | 2.39% | 46.72% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$453.09B | 7.80 | 11.53% | 2.05% | 48.94% | 36.64% | |
67 Neutral | HK$151.26B | 7.74 | 9.55% | 3.83% | 38.36% | 19.98% | |
57 Neutral | HK$187.21B | 9.77 | 8.46% | 2.92% | 28.52% | 6.24% |